Levetiracetam for busulfan-induced seizure prophylaxis in children undergoing hematopoietic stem cell transplantation

被引：30
|
作者：
Soni, Sandeep [1 ]
Skeens, Micah [1 ]
Termuhlen, Amanda M. [1 ]
Bajwa, Rajinder P. S. [1 ]
Gross, Thomas G. [1 ]
Pai, Vinita [1 ,2 ]
机构：
[1] Nationwide Childrens Hosp, Div Pediat Hematol Oncol & BMT, Columbus, OH 43205 USA
[2] Ohio State Univ, Coll Pharm, Columbus, OH 43210 USA
来源：
PEDIATRIC BLOOD & CANCER | 2012年 / 59卷 / 04期
关键词：
BMT; busulfan; levetiracetam; seizures; HIGH-DOSE BUSULFAN; ACUTE-LEUKEMIA PATIENTS; MARROW TRANSPLANTATION; DRUG-INTERACTIONS; PHARMACOKINETICS; CYCLOPHOSPHAMIDE; LORAZEPAM;
D O I：
10.1002/pbc.24126
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Anti-seizure prophylaxis is routinely utilized during busulfan administration for HSCT. We evaluated the feasibility and efficacy of levetiracetam in children undergoing HSCT. A total of 28 children and young adults received levetiracetam during HSCT and the outcomes and costs were compared to a historical, but similar cohort of 25 patients who had received fosphenytoin. Levetiracetam was well tolerated and was efficacious in preventing seizures. Cost of drug, administration, and monitoring were also similar among the two groups. Due to non-induction of the hepatic cytochrome P450 enzymes, levetiracetam may lead to better dose assurance of busulfan in targeted dose regimens for HSCT. Pediatr Blood Cancer 2012;59:762764. (c) 2012 Wiley Periodicals, Inc.
引用
收藏
页码：762 / 764
页数：3
相关论文
共 50 条
  • [1] Phenytoin Versus Levetiracetam for Busulfan-Induced Seizure Prophylaxis and Hematopoietic Stem Cell Transplantation Outcomes
    Farhan, Shatha
    Neme, Klodiana
    Mikulandric, Nancy
    Pelland, Danielle
    Wautelet, Susan
    Szymanski, Sarah
    Ruemenapp, Kenneth
    Trapp, Mary Ann
    Peres, Edward
    Janakiraman, Nalini
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) : S221 - S221
  • [2] Comparison of clonazepam and levetiracetam in children for prevention of busulfan-induced seizure in hematopoietic stem cell transplantation
    Tsujimoto, Shin-ichi
    Shirai, Ryota
    Utano, Tomoyuki
    Osumi, Tomoo
    Matsumoto, Kana
    Shioda, Yoko
    Kiyotani, Chikako
    Uchiyama, Toru
    Deguchi, Takao
    Terashima, Keita
    Tomizawa, Daisuke
    Matsumoto, Kimikazu
    Kato, Motohiro
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2020, 111 (03) : 463 - 466
  • [3] Comparison of clonazepam and levetiracetam in children for prevention of busulfan-induced seizure in hematopoietic stem cell transplantation
    Shin-ichi Tsujimoto
    Ryota Shirai
    Tomoyuki Utano
    Tomoo Osumi
    Kana Matsumoto
    Yoko Shioda
    Chikako Kiyotani
    Toru Uchiyama
    Takao Deguchi
    Keita Terashima
    Daisuke Tomizawa
    Kimikazu Matsumoto
    Motohiro Kato
    International Journal of Hematology, 2020, 111 : 463 - 466
  • [4] Optimal regimen of levetiracetam for prevention of busulfan-induced seizure in patients undergoing hematopoietic stem cell transplantation: A review of available evidence
    Tavajohi, Rayeheh
    Shahrami, Bita
    Rostami, Tahereh
    Kiumarsi, Azadeh
    Honarmand, Hooshyar
    Hadjibabaie, Molouk
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2023, 29 (04) : 927 - 933
  • [5] Comparison of valproate and levetiracetam for the prevention of busulfan-induced seizures in hematopoietic stem cell transplantation
    Toshihisa Nakashima
    Takashi Tanaka
    Keiichi Koido
    Yukiko Nishibuchi
    Hironobu Hashimoto
    Ayumu Ito
    Yoshihiro Inamoto
    Saiko Kurosawa
    Sung-Won Kim
    Takahiro Fukuda
    Hiroyuki Terakado
    International Journal of Hematology, 2019, 109 : 694 - 699
  • [6] Safety, Efficacy, and Favorability of Utilizing Levetiracetam for Busulfan-Induced Seizure Prophylaxis in Pediatric Patients Undergoing Hematopoietic Cell Transplant (HCT)
    Bailey-Olson, Mara
    Long-Boyle, Jane
    Horn, Biljana
    Cowan, Morton J.
    Wahlstrom, Justin T.
    Dvorak, Christopher C.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (02) : S257 - S257
  • [7] Comparison of valproate and levetiracetam for the prevention of busulfan-induced seizures in hematopoietic stem cell transplantation
    Nakashima, Toshihisa
    Tanaka, Takashi
    Koido, Keiichi
    Nishibuchi, Yukiko
    Hashimoto, Hironobu
    Ito, Ayumu
    Inamoto, Yoshihiro
    Kurosawa, Saiko
    Kim, Sung-Won
    Fukuda, Takahiro
    Terakado, Hiroyuki
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2019, 109 (06) : 694 - 699
  • [8] Levetiracetam for the prevention of busulfan-induced seizures in pediatric hematopoietic cell transplantation recipients
    Floeter, Abby E.
    McCune, Jeannine S.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2017, 23 (05) : 344 - 349
  • [9] Phenytoin as seizure prophylaxis in hematopoietic stem cell transplantation with busulfan conditioning
    Germeraad, R. S.
    Demandt, A. M. P.
    Rouhl, R. P. W.
    FRONTIERS IN NEUROLOGY, 2022, 13
  • [10] Comparison of levetiracetam with phenytoin for the prevention of intravenous busulfan-induced seizures in hematopoietic cell transplantation recipients
    Akiyama, Kana
    Kume, Tetsuo
    Fukaya, Masafumi
    Shiki, Ikue
    Enami, Terukazu
    Tatara, Raine
    Shino, Michihiro
    Ikeda, Takashi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 82 (04) : 717 - 721
12345